Search Results 461-470 of 24116 for Crohns disease

1. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

   The purpose of this study is to evaluate the effects, safety and how OPS-2071 (150, 300, or 600 mg twice a day [BID]) is as an add-on therapy in Crohn's disease ...

2. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

   Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

3. Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease - Mayo Clinic

   The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease. The study will test ...

4. Improving the Quality of Care for Adults with Inflammatory Bowel Disease - Mayo Clinic

   The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...

5. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

   Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

6. Digestive Diseases News - Medical Professionals - Mayo Clinic

   Surgery remains an important treatment option for pediatric inflammatory bowel disease (IBD). New medications have improved pediatric IBD care, but surgery is ...

7. Phase IIa Study Evaluating AZD7798 in Crohn's Disease (AMALTHEA) - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease. Participation eligibility.

8. Pilot Study on FDG PET/MRE for Stricture Assessment in Crohn’s Disease - Mayo Clinic

   ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

9. A Study to Test the Safety and Effectiveness of PF-00547659 for Patients who have Crohn's Disease - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is clinically ...

10. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    The SECURE Registry's target enrollment is 4000 patients and it's objective is to monitor patients for approximately 10 years. Participation eligibility.